AustraliaBreaking News

NeuroScientific Biopharmaceuticals (ASX:NSB) has announced encouraging results from its Special Access Program for patients with fistulising Crohn's disease.

Strategic Energy Resources (ASX:SER) has announced the results of its 2025 diamond drilling program at the Canobie Project in Queensland.

Pivotal Metals (ASX:PVT) has reported results from its recent induced polarisation survey at the Lorraine mine target.

Lynas Rare Earths (ASX:LYC) has announced that CEO and Managing Director Amanda Lacaze will retire after 12 years at the helm.

Kingsgate Consolidated (ASX:KCN) has reported production of 20,957 ounces of gold and 157,542 ounces of silver in the December 2025 quarter.

Investment management firm GQG Partners saw its funds under management fall by US$2.2 billion in December 2025, as net outflows for the year more than doubled.

LTR Pharma (ASX:LTP) has commenced patient recruitment for its Phase 2 pharmacokinetic study of SPONTAN, the company's rapid-acting intranasal spray for the treatment of erectile dysfunction, in Australia.

DPM Metals (ASX:DPM) reported preliminary production results for the fourth quarter and full year ended Dec. 31, 2025, marking the eleventh consecutive year the company has met its gold production guidance

Tetratherix (ASX:TTX) has announced a major clinical milestone for its TetraDerm product, with the completion of the second safety review of the trial’s second cohort.

Endeavour Group (ASX:EDV) reported modest sales growth but softer earnings in a trading update for the first half of the 2026 financial year ended Jan. 4.

Fletcher Building (ASX:FBU) has released its quarterly update on key product sales volumes for the second quarter of FY26, reporting a modest improvement in volumes compared with Q1 FY26.

Kevin Rudd will step down as Australia's ambassador to the United States at the end of March, a year earlier than scheduled.